CN110694048A - Raspberry ginseng and medlar tablet and preparation method thereof - Google Patents
Raspberry ginseng and medlar tablet and preparation method thereof Download PDFInfo
- Publication number
- CN110694048A CN110694048A CN201911069215.8A CN201911069215A CN110694048A CN 110694048 A CN110694048 A CN 110694048A CN 201911069215 A CN201911069215 A CN 201911069215A CN 110694048 A CN110694048 A CN 110694048A
- Authority
- CN
- China
- Prior art keywords
- extract powder
- parts
- raspberry
- ginseng
- black
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000011034 Rubus glaucus Nutrition 0.000 title claims abstract description 49
- 235000009122 Rubus idaeus Nutrition 0.000 title claims abstract description 49
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title claims abstract description 30
- 235000003140 Panax quinquefolius Nutrition 0.000 title claims abstract description 30
- 235000008434 ginseng Nutrition 0.000 title claims abstract description 30
- 235000017784 Mespilus germanica Nutrition 0.000 title claims abstract description 23
- 244000182216 Mimusops elengi Species 0.000 title claims abstract description 23
- 235000000560 Mimusops elengi Nutrition 0.000 title claims abstract description 23
- 235000007837 Vangueria infausta Nutrition 0.000 title claims abstract description 23
- 244000235659 Rubus idaeus Species 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims description 10
- 244000131316 Panax pseudoginseng Species 0.000 title 1
- 239000000843 powder Substances 0.000 claims abstract description 202
- 239000000284 extract Substances 0.000 claims abstract description 161
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 38
- 240000000759 Lepidium meyenii Species 0.000 claims abstract description 31
- 235000000421 Lepidium meyenii Nutrition 0.000 claims abstract description 31
- 235000012902 lepidium meyenii Nutrition 0.000 claims abstract description 31
- 241000255789 Bombyx mori Species 0.000 claims abstract description 30
- 241000208688 Eucommia Species 0.000 claims abstract description 30
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 30
- 241000237502 Ostreidae Species 0.000 claims abstract description 30
- 235000020636 oyster Nutrition 0.000 claims abstract description 30
- 241000208340 Araliaceae Species 0.000 claims abstract description 29
- 240000000249 Morus alba Species 0.000 claims abstract description 27
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 26
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 26
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 26
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 24
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 24
- 235000010447 xylitol Nutrition 0.000 claims abstract description 24
- 239000000811 xylitol Substances 0.000 claims abstract description 24
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 24
- 229960002675 xylitol Drugs 0.000 claims abstract description 24
- 239000009141 Houttuynia cordata plant extract Substances 0.000 claims abstract description 20
- 235000020710 ginseng extract Nutrition 0.000 claims abstract description 20
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 20
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 19
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 19
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 19
- 238000002156 mixing Methods 0.000 claims description 12
- 240000000691 Houttuynia cordata Species 0.000 claims description 10
- 235000013719 Houttuynia cordata Nutrition 0.000 claims description 10
- 239000008187 granular material Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 238000004513 sizing Methods 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 4
- 241000756042 Polygonatum Species 0.000 claims description 3
- 239000007779 soft material Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 2
- 235000013305 food Nutrition 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 abstract description 4
- 230000036039 immunity Effects 0.000 abstract description 3
- 201000001881 impotence Diseases 0.000 abstract description 3
- 206010036596 premature ejaculation Diseases 0.000 abstract description 3
- 206010028980 Neoplasm Diseases 0.000 abstract description 2
- 230000032683 aging Effects 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract description 2
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 210000003127 knee Anatomy 0.000 abstract description 2
- 210000004185 liver Anatomy 0.000 abstract description 2
- 230000036299 sexual function Effects 0.000 abstract description 2
- 208000010228 Erectile Dysfunction Diseases 0.000 abstract 1
- 206010059013 Nocturnal emission Diseases 0.000 abstract 1
- 240000007651 Rubus glaucus Species 0.000 description 30
- 239000003826 tablet Substances 0.000 description 18
- 241000218231 Moraceae Species 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000006189 buccal tablet Substances 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 241000123889 Rubus chingii Species 0.000 description 1
- 241001618264 Rubus coreanus Species 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000004789 organ system Anatomy 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Insects & Arthropods (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Anesthesiology (AREA)
- Animal Husbandry (AREA)
- Biomedical Technology (AREA)
- Nutrition Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A raspberry ginseng medlar tablet comprises the following components: raspberry extract powder, black maca extract powder, oyster peptide, black wolfberry extract powder, mulberry extract powder, houttuynia cordata extract powder, rhizoma polygonati extract powder, silkworm chrysalis extract powder, kudzu vine root extract powder, eucommia male flower extract powder, ginseng extract powder and xylitol, wherein the weight parts of the components are as follows: 20-44 parts of raspberry extract powder, 20-40 parts of black maca extract powder, 2-6 parts of oyster peptide, 2-6 parts of black wolfberry extract powder, 2-6 parts of mulberry extract powder, 2-4 parts of houttuynia cordata extract powder, 2-4 parts of rhizoma polygonati extract powder, 2-4 parts of silkworm chrysalis extract powder, 2-4 parts of radix puerariae extract powder, 1-3 parts of eucommia male flower extract powder, 1-3 parts of ginseng extract powder, 5-14 parts of xylitol and 0.1-1 part of magnesium stearate. The Rubi fructus, radix Ginseng and fructus Lycii tablet has effects of invigorating kidney, stopping nocturnal emission, protecting liver, improving sexual impotence, premature ejaculation, soreness of waist and knees, improving sexual function, relieving fatigue, improving sleep, and preventing tumor, thereby enhancing immunity and delaying aging.
Description
Technical Field
The invention relates to the technical field of ginseng and wolfberry tablets, in particular to a raspberry ginseng and wolfberry tablet and a preparation method thereof.
Background
Along with the rapid pace of life of modern people, the social competition is intensified, people are nervous to work in busy, the living pressure is high, the long-term fatigue such as physical strength, mental strength and the like of people is accumulated, the body is tired, the sleep quality is poor, the memory is seriously reduced, the immunity is poor, and the diet is irregular and unhealthy, so that the free genes in the human body are excessive, people are more and more advanced to the direction of sub-health, and if the balance of the free genes in the human body is broken, the free genes can generate a strong injury function and can generate certain influence on organs or immune systems and the like in the human body, so that the people are separated from the sub-health state, and the important significance is achieved in preventing various diseases.
Rubi fructus, also known as Rubus chingii, Rubus coreanus, milk cow, and Rubi fructus. The immature fruit is used as a medicine, has the functions of tonifying the kidney, securing essence, reducing urination and the like, and is used for treating kidney deficiency, frequent urination, impotence, premature ejaculation, spermatorrhea and the like;
with the knowledge and improvement of nutrient components of maca, oysters, black medlars, mulberries, houttuynia cordata thunb, sealwort, silkworm chrysalis, kudzu roots, eucommia male flowers, ginseng and the like, the traditional eating mode of the raspberry, maca, oysters, black medlars, mulberries, houttuynia cordata thunb, sealwort, silkworm chrysalis, kudzu roots, eucommia male flowers and ginseng is broken through by combining the maca with the raspberry to prepare the sugar-containing composite buccal tablets, and the sugar-containing composite buccal tablets have very important significance for further realizing deep processing and high-value utilization of the raspberry, maca, oysters, black medlars, mulberries, houttuynia cordata thunb, sealwort, silkworm chrysalis, kudzu roots, eucommia male flowers and ginseng.
Disclosure of Invention
The invention aims to provide a raspberry ginseng and wolfberry tablet and a preparation method thereof, and aims to solve the problems in the background technology.
In order to achieve the purpose, the invention provides the following technical scheme that the raspberry-ginseng-wolfberry tablet comprises the following components: the health-care tea comprises main raspberry extract powder, black maca extract powder, oyster peptide, black wolfberry extract powder, mulberry extract powder, houttuynia cordata extract powder, rhizoma polygonati extract powder, silkworm chrysalis extract powder, kudzu vine root extract powder, eucommia male flower extract powder, ginseng extract powder, xylitol and magnesium stearate, wherein the ratio of parts by weight of the components is as follows: 20-44 parts of raspberry extract powder, 20-40 parts of black maca extract powder, 2-6 parts of oyster peptide, 2-6 parts of black wolfberry extract powder, 2-6 parts of mulberry extract powder, 2-4 parts of houttuynia cordata extract powder, 2-4 parts of rhizoma polygonati extract powder, 2-4 parts of silkworm chrysalis extract powder, 2-4 parts of radix puerariae extract powder, 1-3 parts of eucommia male flower extract powder, 1-3 parts of ginseng extract powder, 5-14 parts of xylitol and 0.1-1 part of magnesium stearate.
Preferably, the raspberry ginseng medlar tablet comprises the following components in parts by weight: 20 parts of raspberry extract powder, 20 parts of black maca extract powder, 2 parts of oyster peptide, 2 parts of black wolfberry extract powder, 2 parts of mulberry extract powder, 2 parts of houttuynia cordata extract powder, 2 parts of polygonatum extract powder, 2 parts of silkworm chrysalis extract powder, 2 parts of kudzu root extract powder, 1 part of eucommia male flower extract powder, 1 part of ginseng extract powder, 5 parts of xylitol and 0.1 part of magnesium stearate.
Preferably, the raspberry ginseng medlar tablet comprises the following components in parts by weight: 44 parts of raspberry extract powder, 40 parts of black maca extract powder, 6 parts of oyster peptide, 6 parts of black wolfberry extract powder, 6 parts of mulberry extract powder, 4 parts of houttuynia cordata extract powder, 4 parts of rhizoma polygonati extract powder, 4 parts of silkworm chrysalis extract powder, 4 parts of radix puerariae extract powder, 3 parts of eucommia male flower extract powder, 3 parts of ginseng extract powder, 14 parts of xylitol and 1 part of magnesium stearate.
Preferably, the raspberry ginseng medlar tablet comprises the following components in parts by weight: 32 parts of raspberry extract powder, 30 parts of black maca extract powder, 4 parts of oyster peptide, 4 parts of black wolfberry extract powder, 4 parts of mulberry extract powder, 3 parts of houttuynia cordata extract powder, 3 parts of rhizoma polygonati extract powder, 3 parts of silkworm chrysalis extract powder, 3 parts of radix puerariae extract powder, 2 parts of eucommia male flower extract, 1-3 parts of ginseng extract powder, 9.5 parts of xylitol and 0.5 part of magnesium stearate.
Preferably, the preparation method of the raspberry-ginseng-wolfberry tablet specifically comprises the following steps:
1) material preparation: preparing raspberry, maca, oyster, black medlar, mulberry, houttuynia cordata, sealwort, silkworm chrysalis, kudzu vine root, eucommia male flower, ginseng and xylitol, and simultaneously concentrating the raspberry, the maca, the oyster, the black medlar, the mulberry, the houttuynia cordata, the sealwort, the silkworm chrysalis, the kudzu vine root, the eucommia male flower and the ginseng into powder through a substitute extraction process;
2) mixing: mixing raspberry extract powder, black maca extract powder, oyster peptide, black wolfberry extract powder, mulberry extract powder, houttuynia cordata extract powder, rhizoma polygonati extract powder, silkworm chrysalis extract powder, kudzu vine root extract powder, eucommia male flower extract powder, ginseng extract powder and xylitol on a multi-dimensional stereo mixer for 40 minutes to uniformly mix the materials to obtain a mixture;
3) and (3) granulating: adding 95% edible ethanol into the mixture, mixing to obtain soft material, granulating on a swing type granulator with a 16-mesh granulating screen to obtain wet granules;
4) and (3) drying: drying the wet granules at 50-60 ℃ for 4-5 hours until the moisture content is 3% -4%;
5) finishing the grains: the dried particles are sized through a sizing screen, the mesh number of the sizing screen is 20 meshes, and the moisture of the sized particles is controlled to be 3-4%;
6) tabletting: adding magnesium stearate into the granulated dry granules, mixing, and tabletting.
Compared with the prior art, the invention has the beneficial effects that: the raspberry ginseng medlar tablet can tonify kidney, secure essence and protect liver, is beneficial to improving symptoms such as impotence, premature ejaculation and soreness and weakness of waist and knees, enhances sexual function, resists fatigue, improves sleep and prevents tumors so as to achieve the effects of enhancing immunity and delaying aging, meanwhile, the tablet is prepared by adopting a tabletting process, has the advantages of better absorbing various nutritional ingredients, being easy to carry and convenient to eat, meanwhile, raspberry, maca, oyster, black medlar, mulberry, houttuynia cordata, rhizoma polygonati, silkworm chrysalis, radix puerariae, eucommia male flowers and ginseng are concentrated into powder by a substitution extraction process so as to play higher effective ingredients, fructo-oligosaccharide is matched as an auxiliary material to adjust the taste, effectively helping intestinal tracts to absorb various nutritional ingredients, xylitol is added into granulated dry particles to be uniformly mixed, the taste of the tablet can be better adjusted, and the tablet weight stability can be better increased.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The invention provides a technical scheme that:
example 1:
a raspberry ginseng medlar tablet comprises the following components: the health-care tea comprises main raspberry extract powder, black maca extract powder, oyster peptide, black wolfberry extract powder, mulberry extract powder, houttuynia cordata extract powder, rhizoma polygonati extract powder, silkworm chrysalis extract powder, kudzu vine root extract powder, eucommia male flower extract powder, ginseng extract powder, xylitol and magnesium stearate, wherein the ratio of parts by weight of the components is as follows: 20-44 parts of raspberry extract powder, 20-40 parts of black maca extract powder, 2-6 parts of oyster peptide, 2-6 parts of black wolfberry extract powder, 2-6 parts of mulberry extract powder, 2-4 parts of houttuynia cordata extract powder, 2-4 parts of rhizoma polygonati extract powder, 2-4 parts of silkworm chrysalis extract powder, 2-4 parts of radix puerariae extract powder, 1-3 parts of eucommia male flower extract powder, 1-3 parts of ginseng extract powder, 5-14 parts of xylitol and 0.1-1 part of magnesium stearate.
Example 2:
the raspberry ginseng medlar tablet comprises the following components in parts by weight: 20 parts of raspberry extract powder, 20 parts of black maca extract powder, 2 parts of oyster peptide, 2 parts of black wolfberry extract powder, 2 parts of mulberry extract powder, 2 parts of houttuynia cordata extract powder, 2 parts of polygonatum extract powder, 2 parts of silkworm chrysalis extract powder, 2 parts of kudzu root extract powder, 1 part of eucommia male flower extract powder, 1 part of ginseng extract powder, 5 parts of xylitol and 0.1 part of magnesium stearate.
Example 3:
the raspberry ginseng medlar tablet comprises the following components in parts by weight: 44 parts of raspberry extract powder, 40 parts of black maca extract powder, 6 parts of oyster peptide, 6 parts of black wolfberry extract powder, 6 parts of mulberry extract powder, 4 parts of houttuynia cordata extract powder, 4 parts of rhizoma polygonati extract powder, 4 parts of silkworm chrysalis extract powder, 4 parts of radix puerariae extract powder, 3 parts of eucommia male flower extract powder, 3 parts of ginseng extract powder, 14 parts of xylitol and 1 part of magnesium stearate.
Example 4:
the raspberry ginseng medlar tablet comprises the following components in parts by weight: 32 parts of raspberry extract powder, 30 parts of black maca extract powder, 4 parts of oyster peptide, 4 parts of black wolfberry extract powder, 4 parts of mulberry extract powder, 3 parts of houttuynia cordata extract powder, 3 parts of rhizoma polygonati extract powder, 3 parts of silkworm chrysalis extract powder, 3 parts of radix puerariae extract powder, 2 parts of eucommia male flower extract, 1-3 parts of ginseng extract powder, 9.5 parts of xylitol and 0.5 part of magnesium stearate.
Example 5:
the preparation method of the raspberry-ginseng-wolfberry tablet specifically comprises the following steps:
1) material preparation: preparing raspberry, maca, oyster, black medlar, mulberry, houttuynia cordata, sealwort, silkworm chrysalis, kudzu vine root, eucommia male flower, ginseng and xylitol, and simultaneously concentrating the raspberry, the maca, the oyster, the black medlar, the mulberry, the houttuynia cordata, the sealwort, the silkworm chrysalis, the kudzu vine root, the eucommia male flower and the ginseng into powder through a substitute extraction process;
2) mixing: mixing raspberry extract powder, black maca extract powder, oyster peptide, black wolfberry extract powder, mulberry extract powder, houttuynia cordata extract powder, rhizoma polygonati extract powder, silkworm chrysalis extract powder, kudzu vine root extract powder, eucommia male flower extract powder, ginseng extract powder and xylitol on a multi-dimensional stereo mixer for 40 minutes to uniformly mix the materials to obtain a mixture;
3) and (3) granulating: adding 95% edible ethanol into the mixture, mixing to obtain soft material, granulating on a swing type granulator with a 16-mesh granulating screen to obtain wet granules;
4) and (3) drying: drying the wet granules at 50-60 ℃ for 4-5 hours until the moisture content is 3% -4%;
5) finishing the grains: the dried particles are sized through a sizing screen, the mesh number of the sizing screen is 20 meshes, and the moisture of the sized particles is controlled to be 3-4%;
6) tabletting: adding magnesium stearate into the granulated dry granules, mixing, and tabletting.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.
Claims (5)
1. A raspberry ginseng medlar tablet comprises the following components: the health-care food is characterized by comprising main raspberry extract powder, black maca extract powder, oyster peptide, black wolfberry extract powder, mulberry extract powder, houttuynia cordata extract powder, rhizoma polygonati extract powder, silkworm chrysalis extract powder, kudzu root extract powder, eucommia male flower extract powder, ginseng extract powder, xylitol and magnesium stearate, wherein the main raspberry extract powder comprises the following components in percentage by weight: the weight parts of the components are as follows: 20-44 parts of raspberry extract powder, 20-40 parts of black maca extract powder, 2-6 parts of oyster peptide, 2-6 parts of black wolfberry extract powder, 2-6 parts of mulberry extract powder, 2-4 parts of houttuynia cordata extract powder, 2-4 parts of rhizoma polygonati extract powder, 2-4 parts of silkworm chrysalis extract powder, 2-4 parts of radix puerariae extract powder, 1-3 parts of eucommia male flower extract powder, 1-3 parts of ginseng extract powder, 5-14 parts of xylitol and 0.1-1 part of magnesium stearate.
2. The raspberry, ginseng and wolfberry tablet of claim 1, wherein: the weight parts of the components are as follows: 20 parts of raspberry extract powder, 20 parts of black maca extract powder, 2 parts of oyster peptide, 2 parts of black wolfberry extract powder, 2 parts of mulberry extract powder, 2 parts of houttuynia cordata extract powder, 2 parts of polygonatum extract powder, 2 parts of silkworm chrysalis extract powder, 2 parts of kudzu root extract powder, 1 part of eucommia male flower extract powder, 1 part of ginseng extract powder, 5 parts of xylitol and 0.1 part of magnesium stearate.
3. The raspberry, ginseng and wolfberry tablet of claim 1, wherein: the weight parts of the components are as follows: 44 parts of raspberry extract powder, 40 parts of black maca extract powder, 6 parts of oyster peptide, 6 parts of black wolfberry extract powder, 6 parts of mulberry extract powder, 4 parts of houttuynia cordata extract powder, 4 parts of rhizoma polygonati extract powder, 4 parts of silkworm chrysalis extract powder, 4 parts of radix puerariae extract powder, 3 parts of eucommia male flower extract powder, 3 parts of ginseng extract powder, 14 parts of xylitol and 1 part of magnesium stearate.
4. The raspberry, ginseng and wolfberry tablet of claim 1, wherein: the weight parts of the components are as follows: 32 parts of raspberry extract powder, 30 parts of black maca extract powder, 4 parts of oyster peptide, 4 parts of black wolfberry extract powder, 4 parts of mulberry extract powder, 3 parts of houttuynia cordata extract powder, 3 parts of rhizoma polygonati extract powder, 3 parts of silkworm chrysalis extract powder, 3 parts of radix puerariae extract powder, 2 parts of eucommia male flower extract, 1-3 parts of ginseng extract powder, 9.5 parts of xylitol and 0.5 part of magnesium stearate.
5. The preparation method of the raspberry ginseng medlar tablet according to any one of 1 to 4 is characterized by comprising the following steps: the method specifically comprises the following steps:
1) material preparation: preparing raspberry, maca, oyster, black medlar, mulberry, houttuynia cordata, sealwort, silkworm chrysalis, kudzu vine root, eucommia male flower, ginseng and xylitol, and simultaneously concentrating the raspberry, the maca, the oyster, the black medlar, the mulberry, the houttuynia cordata, the sealwort, the silkworm chrysalis, the kudzu vine root, the eucommia male flower and the ginseng into powder through a substitute extraction process;
2) mixing: mixing raspberry extract powder, black maca extract powder, oyster peptide, black wolfberry extract powder, mulberry extract powder, houttuynia cordata extract powder, rhizoma polygonati extract powder, silkworm chrysalis extract powder, kudzu vine root extract powder, eucommia male flower extract powder, ginseng extract powder and xylitol on a multi-dimensional stereo mixer for 40 minutes to uniformly mix the materials to obtain a mixture;
3) and (3) granulating: adding 95% edible ethanol into the mixture, mixing to obtain soft material, granulating on a swing type granulator with a 16-mesh granulating screen to obtain wet granules;
4) and (3) drying: drying the wet granules at 50-60 ℃ for 4-5 hours until the moisture content is 3% -4%;
5) finishing the grains: the dried particles are sized through a sizing screen, the mesh number of the sizing screen is 20 meshes, and the moisture of the sized particles is controlled to be 3-4%;
6) tabletting: adding magnesium stearate into the granulated dry granules, mixing, and tabletting.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911069215.8A CN110694048A (en) | 2019-11-05 | 2019-11-05 | Raspberry ginseng and medlar tablet and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911069215.8A CN110694048A (en) | 2019-11-05 | 2019-11-05 | Raspberry ginseng and medlar tablet and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110694048A true CN110694048A (en) | 2020-01-17 |
Family
ID=69204285
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911069215.8A Pending CN110694048A (en) | 2019-11-05 | 2019-11-05 | Raspberry ginseng and medlar tablet and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110694048A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111773374A (en) * | 2020-07-07 | 2020-10-16 | 深圳市清大生物科技有限公司 | Formula of sealwort oyster peptide for improving immunity |
| CN113397174A (en) * | 2021-06-29 | 2021-09-17 | 李晓琳 | Production process of peptide-containing crocodile food |
| CN113457937A (en) * | 2021-08-12 | 2021-10-01 | 徐根花 | Automatic oiling station of nozzle valve piston |
| CN115462522A (en) * | 2021-09-23 | 2022-12-13 | 王伟华 | Composition with effects of tonifying kidney, improving prostate and improving mental state |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107496701A (en) * | 2017-09-21 | 2017-12-22 | 成都原之精生物科技有限公司 | A kind of production of sperm and the formula for treating impotence and premature ejaculation |
| CN109010674A (en) * | 2018-08-28 | 2018-12-18 | 岚皋县硒安生物科技有限公司 | One kind tonifies the kidney to relieve mental strain Chinese medicine composition |
| CN109276649A (en) * | 2018-12-05 | 2019-01-29 | 灵参生物科技（大连）有限公司 | A kind of pharmaceutical composition, tonifying speen and tonifying kidney soup and preparation method thereof |
| CN110327421A (en) * | 2019-01-04 | 2019-10-15 | 威海赛瑞航天科技有限公司 | A kind of suitable astronaut has the composition of raising energy and coordination each organ dysfunction of human body |
-
2019
- 2019-11-05 CN CN201911069215.8A patent/CN110694048A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107496701A (en) * | 2017-09-21 | 2017-12-22 | 成都原之精生物科技有限公司 | A kind of production of sperm and the formula for treating impotence and premature ejaculation |
| CN109010674A (en) * | 2018-08-28 | 2018-12-18 | 岚皋县硒安生物科技有限公司 | One kind tonifies the kidney to relieve mental strain Chinese medicine composition |
| CN109276649A (en) * | 2018-12-05 | 2019-01-29 | 灵参生物科技（大连）有限公司 | A kind of pharmaceutical composition, tonifying speen and tonifying kidney soup and preparation method thereof |
| CN110327421A (en) * | 2019-01-04 | 2019-10-15 | 威海赛瑞航天科技有限公司 | A kind of suitable astronaut has the composition of raising energy and coordination each organ dysfunction of human body |
Non-Patent Citations (1)
| Title |
|---|
| 张兆旺, 中国中医药出版社 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111773374A (en) * | 2020-07-07 | 2020-10-16 | 深圳市清大生物科技有限公司 | Formula of sealwort oyster peptide for improving immunity |
| CN113397174A (en) * | 2021-06-29 | 2021-09-17 | 李晓琳 | Production process of peptide-containing crocodile food |
| CN113457937A (en) * | 2021-08-12 | 2021-10-01 | 徐根花 | Automatic oiling station of nozzle valve piston |
| CN115462522A (en) * | 2021-09-23 | 2022-12-13 | 王伟华 | Composition with effects of tonifying kidney, improving prostate and improving mental state |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110694048A (en) | Raspberry ginseng and medlar tablet and preparation method thereof | |
| CN103141684B (en) | Composite rabbit feed containing Chinese medicinal herbs | |
| CN1095952A (en) | A kind of production method of medicated tea | |
| CN103141678B (en) | Composite goose feed containing Chinese medicinal herbs | |
| WO2022062716A1 (en) | Composition having function of nourishing yin and tonifying kidney, and preparation method therefor and use thereof | |
| CN106359791A (en) | Deer blood tableted candy and production method thereof | |
| CN108308450A (en) | A kind of feed addictive and preparation method thereof of broiler chicken prophyiaxis and promoting growth | |
| CN106343343A (en) | Lithocarpus polystachyus (DC.) Rehd tartarian buckwheat composition for reducing three-high and application thereof | |
| CN105852084A (en) | Functional food composition capable of reducing weight and reducing blood lipid and preparation method of functional food composition | |
| CN107183295A (en) | A kind of blood bores wild oat pressed candy | |
| CN103141680B (en) | Composite cattle feed containing Chinese medicinal herbs | |
| CN108244379A (en) | Somatotrophic feed addictive of a kind of children rabbit and preparation method thereof | |
| CN105941879A (en) | Feed for mutton sheep | |
| CN108617853A (en) | The feed addictive and preparation method for promoting chick growth, improving laying rate of laying hen | |
| CN108464406A (en) | The broiler fodder and preparation method thereof for promoting growth of meat chicken, improving meat flavor | |
| CN108522888A (en) | A kind of feed and preparation method thereof for promoting chick growth, improving laying rate of laying hen | |
| CN110604306A (en) | Composite buccal tablet containing agaricus bisporus extract powder and preparation method | |
| CN110663948A (en) | Health product with immunity enhancing effect and preparation method thereof | |
| CN109172507A (en) | A kind of whitening dissipates and preparation method thereof | |
| CN108552432A (en) | A kind of egg feedstuff and preparation method thereof improving laying rate of laying hen | |
| CN106262540A (en) | A kind of preparation method of sesame paste | |
| CN104225187A (en) | Preparation method of rhizoma anemarrhenae and golden cypress rehmannia pill with treated coating | |
| CN105168952A (en) | Compound maca health care product | |
| CN110800839A (en) | Functional health-care tea | |
| CN116440178A (en) | Preparation process of composite fungus polysaccharide with cell repair function |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200117 |